» Subscribe Today!
The Power of Information
Home
The Ledger - EST. 1978 - Nashville Edition
X
Skip Navigation LinksHome > Article
VOL. 39 | NO. 19 | Friday, May 8, 2015

FDA schedules meeting on twice-rejected female libido drug

Print | Front Page | Email this story

WASHINGTON (AP) — The Food and Drug Administration will ask a group of outside medical experts next month to evaluate a much-debated experimental drug designed to boost sexual desire in women.

The meeting is the latest twist in the FDA's multi-year review of the female libido pill flibanserin, which the agency has twice declined to approve. But the drug's backer, Sprout Pharmaceuticals, has enlisted women's groups and other advocates to lobby the agency to approve the pill, saying women's sexual problems have been long overlooked by the federal government.

The FDA said in a posting it will convene a meeting of its reproductive drugs and drug safety panels on June 4. The agency is not required to follow the advice of such panels, though it often does.

Follow us on Facebook, Twitter & RSS:
Sign-Up For Our FREE email edition
Get the news first with our free weekly email
Name
Email  
TNLedger.com Knoxville Editon
RECORD TOTALS DAY WEEK YEAR
PROPERTY SALES 0 0 0
MORTGAGES 0 0 0
FORECLOSURE NOTICES 0 0 0
BUILDING PERMITS 0 0 0
BANKRUPTCIES 0 0 0
BUSINESS LICENSES 0 0 0
UTILITY CONNECTIONS 0 0 0
MARRIAGE LICENSES 0 0 0